| mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
5e-05 |
| mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |
| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.21 |
6e-05 |
| mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |